2025-03-15T08:47:01-04:00 2024-06-30 851572996 MORIARTY & ASSOCIATES PC 144 GOULD ST STE 205 NEEDHAM MA 02494 990 2023-07-01 843043384 MISSION CURE INC MISS MEGAN GOLDEN 245 W 107TH ST STE 11B NEW YORK NY 10025 MEGAN GOLDEN CEO 4013752873 2025-01-20 true true MICHAEL P MORIARTY CPA P00574082 6178522214 2025-03-15 2023 2025-03-06 01:10:19Z 879472 false X MISSION-CURE.ORG X 2019 DE MISSION:CURE AIMS TO IMPROVE THE HEALTH AND LIVES OF PEOPLE AFFECTED BY COSTLY DISEASES WITH POOR PATIENT OUTCOMES, STARTING WITH PANCREATITIS. 7 7 10 10 0 0 554907 831767 0 6191 47705 -25021 -25625 536077 853847 0 0 305857 382953 0 22728 121951 258921 427808 641874 108269 211973 1037087 1327418 3489 16946 1033598 1310472 MISSION:CURE AIMS TO IMPROVE THE HEALTH AND LIVES OF PEOPLE AFFECTED BY COSTLY DISEASES WITH POOR PATIENT OUTCOMES, STARTING WITH PANCREATITIS. false false 547895 1. DEVELOPING THERAPIES:A) ADVOCATED WITH MULTIPLE LIFE SCIENCES COMPANIES TO PURSUE THERAPIES FOR PANCREATITIS; PROVIDED INFORMATION TO SUPPORT DRUG DEVELOPMENT; B)PRESENTED TO THE FDA ON EFFORTS TO REDUCE RISKS IN DRUG DEVELOPMENT BY ESTABLISHING CLEAR OUTCOME MEASURES FOR CLINICAL TRIALS; C) SELECTED FOR A COMPETITIVE CHAN-ZUCKERBERG INITIATIVE FUNDED PROGRAM TO DEVELOP WEARABLES TO MEASURE PANCREATITIS SYMPTOMS FOR RESEARCH AND CLINICAL USE.2. ENGAGING COMMUNITIES: A) PRODUCED AND DISSEMINATED NEW EDUCATIONAL CONTENT ABOUT NUTRITION, CLINICAL TRIALS AND THE PATIENT EXPERIENCE. B) ENGAGED OVER 10,000 PEOPLE CONNECTED TO PANCREATITIS ACROSS 6 PLATFORMS. PATIENT EDUCATIONAL VIDEOS HAVE OVER 61,000 VIEWS AND 6,226 HOURS OF WATCH TIME.3. IMPROVING CARE: COLLABORATED WITH JOHNS HOPKINS UNIVERSITY TO OPERATE JOHNS HOPKINS PAIN RESEARCH PROGRAM TO EFFECTIVELY TREAT PANCREATITIS. 547895 true true false false false false false false false false false false false false false false false false false false false false false false true false false false false true false false false false false false false false true false false false false false false false false true 8 0 true 10 true false false false false false true true false false false false false false false false X 7 7 false false false false false false false true true false false true true true true true true true true false CA NY X MEGAN GOLDEN 4013752873 245 W 107TH ST APT 11B NEW YORK NY 10025 LOLA RAHIB VP OF TRANSLATIONAL RESEARCH 40.00 0.00 X 150000 0 6938 MEGAN GOLDEN PRESIDENT AND CEO 40.00 0.00 X X 82500 0 0 SAM SHRAUGER BOARD MEMBER 2.00 0.00 X 0 0 0 DEBBIE NIEDERHOFFER BOARD MEMBER 2.00 0.00 X 0 0 0 MICHAEL LEVITAN BOARD MEMBER 2.00 0.00 X 0 0 0 LINDA MARTIN BOARD CHAIRPERSON 8.00 0.00 X X 0 0 0 BRUCE BLOOM SECRETARY 2.00 0.00 X X 0 0 0 JAMES MEDSKER TREASURER 2.00 0.00 X X 0 0 0 232500 0 6938 1 false true false 275487 556280 25599 831767 47705 47705 275487 25625 -25625 -25625 853847 47705 0 -25625 X 82500 65175 17325 262896 241188 12702 9006 7061 6908 121 32 30496 26934 2738 824 17449 17449 199648 182782 4006 12860 9873 4179 5694 23475 19941 3528 6 1158 788 370 1507 1507 BANK CHARGES 3699 3699 PAYROLL PROCESSING 2112 2112 641874 547895 71251 22728 145410 28228 890499 1288204 10000 1178 986 1037087 1327418 3489 16946 3489 16946 X 956773 1269935 76825 40537 1033598 1310472 1037087 1327418 211973 64901 0 X true X false true false X 950164 724152 554907 831676 3060899 950164 724152 554907 831676 3060899 224408 2836491 6191 47705 53896 3114795 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED GALA 275487 275487 25625 275487 275487 25625 25625 -25625 X X false false false false false false false false false LOLA RAHIB VP OF TRANSLATIONAL RESEARCH 150000 6938 156938 X 1 25599 FAIR MARKET VALUE false true true Number of contributions or items or both (Part I, col b) THE AMOUNT REPORTED ON LINE 1B REPRESENTS THE TOTAL NUMBER OF CONTRIBUTIONS RECEIVED. Third party arrangements (Part I, line 32b) THE ORGANIZATION USES A REGISTERED SECURITIES BROKER-DEALER TO RECEIVE, PROCESS AND LIQUIDATE DONATIONS OF PUBLICLY TRADED SECURITIES. THE DONATIONS ARE CONVERTED TO CASH AND THE ORGANIZATION DOES NOT TAKE PHYSICAL POSESSION OF ANY SECURITIES. Form 990 governing body review Part VI line 11 THE ORGANIZATION PROVIDES A DRAFT COPY OF FORM 990 FOR THE BOARD TO REVIEW PRIOR TO FILING Conflict of interest policy compliance Part VI line 12c BOARD MEMBERS AND KEY EMPLOYEES ANNUALLY COMPLETE CONFLICT OF INTEREST DISCLOSURE FORMS. AT EACH BOARD MEETING, BOARD MEMBERS AND THE CEO ARE ASKED TO DISCLOSE ANY NEW CONFLICTS OF INTEREST. CEO executive director top management comp Part VI line 15a COMPENSATION PROCESS FOR TOP OFFICIAL: THE ORGANIZATION USES THE DEPARTMENT OF LABOR STATISTICS AND SALARY GUIDE TO OBTAIN COMPARABLE DATA ON POSITIONS. FURTHERMORE, THE ORGANIZATION PERIODICALLY REVIEWS THE COMPENSATION ARRANGEMENTS AND BENEFITS TO ENSURE THAT THEY ARE REASONABLE, BASED ON COMPETENT SURVEY INFORMATION AND THE RESULT OF ARMS LENGTH BARGAINING. Other officer or key employee compensation Part VI line 15b COMPENSATION PROCESS FOR OTHER OFFICERS AND KEY EMPLOYEES: THE ORGANIZATION USES THE DEPARTMENT OF LABOR STATISTICS AND SALARY GUIDE TO OBTAIN COMPARABLE DATA ON POSITIONS. FURTHERMORE, THE ORGANIZATION PERIODICALLY REVIEWS THE COMPENSATION ARRANGEMENTS AND BENEFITS TO ENSURE THAT THEY ARE REASONABLE, BASED ON COMPETENT SURVEY INFORMATION AND THE RESULT OF ARMS LENGTH BARGAINING. Governing documents etc available to public Part VI line 19 THE FINANCIAL STATEMENTS AND OTHER DOCUMENTS, SUCH AS THE CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS, ARE AVAILABLE UPON REQUEST. List of other fees for services expenses Part IX line 11g OTHER CONSULTING EXPENSES:PROGRAM CONSULTANTS - $117,880IN-KIND CONSULTING SERVICES RECEIVED - $64,901